Skip to main content
Equibles
EYPT logo

EYPT · EyePoint, Inc.

Track EYPT — free

Use EYPT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about EYPT

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$5.40 -0.90 (-14.29%) At close · Aug 20
Market Cap
$512.53M
Shares
86.21M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$5.40 Open$6.18 Day$5.30–6.29 52W close$4.87–18.85 Avg vol 30d4.3M Short int18.0M · 20.9% float · 12.4d Short vol40% Last earningsAug 5, 2026 DataDec 2020–Aug 2026 Filing10-Q · Aug 5

Raw chart and full-history price indicators begin at the captured split on Dec 9, 2020; bars on opposite sides are not compared.

Up next

Next earnings call
Nov 4, 2026 Est · unconfirmed · in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 5, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Fair Quant / Vol Very High
      Market backdrop VIX 14.9 · calm Equity put/call 0.52
      Technical
      price trend
      Strong Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −61%
      below
      Price vs 50-day avg −57%
      below
      RSI (14) 30
      oversold
      MACD trend Negative
      52-week position 4%
      near low
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Weak
      1-month return −57%
      trailing
      6-month return −69%
      trailing
      YTD return −70%
      this year
      Relative strength −80%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $13 › 200d $14 — 200d above 50d
      Institutional flow Flat
      0% holders QoQ · +25 funds added
      Insider flow Accumulating
      Net +$52.3K over 90 days · 0% sells
      Short interest Rising
      20.90% of float · ▲ +9.7% MoM · 12.4 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      192 holders — near 3-yr high, broad support
      Squeeze score 70
      elevated · 0–100
      Fundamentals
      Fair
      Revenue growth +365%
      Y/Y
      EPS growth −37%
      Y/Y
      Free cash flow $-243.4M
      Balance sheet $71.8M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 98%
      annualized · 1-yr
      Max drawdown −74%
      past year
      ATR 27.6%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Technicals

      trend & momentum for long-term holders Strong Sell
      4 · 3 · 0
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −61% Bearish
      Price vs 50-day avg
      −57% Bearish
      RSI (14)
      30 Neutral
      MACD trend
      Negative Bearish
      52-week position
      4% Bearish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $13 › 200d $14 — 200d above 50d
      Institutional flow Flat
      0% holders QoQ · +25 funds added
      Insider flow Accumulating
      Net +$52.3K over 90 days · 0% sells
      Short interest Rising
      20.90% of float · ▲ +9.7% MoM · 12.4 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      192 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $5 Now $5 · 4% Range high $19
      vs 200-day avg -61% vs 50-day avg -57%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Gross proceeds from underwritten public offering $172.5M October 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Biotechnology — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      EYPT
      EyePoint, Inc.
      this stock
      		$512.53M -70.4% +664.9% — 20.9%
      ONC
      BeOne Medicines Ltd.
      		 $557.05B +21.5% +22179.2% 856.5 0.1%
      VRTX
      Vertex Pharmaceuticals Inc / Ma
      		 $136.93B +19.2% +46.2% 31.5 1.6%
      REGN
      Regeneron Pharmaceuticals, Inc.
      		 $86.39B +7.1% +20.8% 20.8 3.3%
      MRNA
      Moderna, Inc.
      		 $69.62B +352.1% +4.3% — 12.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      192
      % held
      111.9%
      Net QoQ
      +5.6M sh
      Top holder
      SUVRETTA CAPITAL MANAGEME…
      Held Float
      View
      Held by Funds
      Fund positions
      167
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      18.0M
      Days to cover
      12.4d
      Change
      +1.6M sh
      View
      Short Volume
      Short vol %
      40%
      As of
      Aug 20, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      30
      Value
      $359
      As of
      Jul 29, 2026
      View
      Off-Exchange
      Off-exchange %
      41.7%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net buying
      Net (90d)
      +$52.3K
      Buyers / Sellers
      1 / 0
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $31.4M
      Net income (FY)
      $-232.0M
      EPS diluted
      $-3.17
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 17, 2026
      This year
      19
      View
      Proposed Sales
      Value
      $5.5M
      Shares
      421.2K
      Filed
      Jul 21, 2026
      View
      Exempt Offerings
      Offering
      $15.7M
      Filed
      Jan 6, 2021
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 5, 2026
      View

      Performance

      Raw-price comparisons begin at the captured split on Dec 9, 2020; windows that need an earlier baseline remain unavailable.

      5D 20D 120D MTD YTD
      EYPT -59.9% -56.7% -69.3% -55.9% -70.4%
      SPY -2.0% +3.3% +11.2% +2.1% +11.8%
      vs SPY -58.0% -60.0% -80.4% -58.0% -82.3%
      Key facts CIK 1314102 CUSIP 30233G209 13F (30d) 184 filings 181 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)